This brand name is authorized in Australia, United Kingdom
The drug COLAZIDE contains one active pharmaceutical ingredient (API):
UNII 1XL6BJI034 - BALSALAZIDE DISODIUM
Balsalazide consists of mesalazine linked to a carrier molecule (4-aminobenzoyl-ß-alanine) via an azo bond. Bacterial azo-reduction releases mesalazine as an active metabolite in the colon. Mesalazine is an intestinal anti-inflammatory agent acting locally on the colonic mucosa. Its precise mechanism of action is unknown.
Below package inserts are available for further reading:
|COLAZIDE Capsule, hard
|Medicines & Healthcare Products Regulatory Agency (GB)
|MPI, EU: SmPC
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
|A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EC Aminosalicylic acid and similar agents
This drug has been assigned below unique identifiers within the countries it is being marketed:
|Pharmaceutical Benefits Scheme
|Medicines & Healthcare Products Regulatory Agency
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.